Zevra Therapeutics (ZVRA) Enterprise Value Growth (1y) (2015 - 2026)
Zevra Therapeutics (ZVRA) Enterprise Value Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -220.31% |
| Dec 31, 2025 | -174.85% |
| Sep 30, 2025 | -123.22% |
| Jun 30, 2025 | -311.33% |
| Mar 31, 2025 | -18.81% |
| Dec 31, 2024 | -2.60% |
| Sep 30, 2024 | -106.56% |
| Jun 30, 2024 | -10,183.51% |
| Mar 31, 2024 | -31.20% |
| Dec 31, 2023 | -2.71% |
| Sep 30, 2023 | 38.24% |
| Jun 30, 2023 | 99.38% |
| Dec 31, 2022 | 41.30% |
| Sep 30, 2022 | 46.72% |
| Jun 30, 2022 | 41.96% |
| Dec 31, 2021 | -2,566.65% |
| Sep 30, 2021 | -2,396.73% |
| Jun 30, 2021 | -1,977.17% |
| Mar 31, 2021 | -3,122.28% |
| Dec 31, 2020 | -30.96% |